CARTESIAN THERAPEUTICS, INC. — Revenue by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/03ffa0c2-11ff-45e2-9c72-ce68722427a6/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $2.8M | 2025-01-01 – 2025-12-31 | evidence 0001453687-26-000064 |
| FY 2024 | $38.3M | 2024-01-01 – 2024-12-31 | evidence 0001453687-25-000060 |
| FY 2023 | $26.0M | 2023-01-01 – 2023-12-31 | evidence 0001453687-24-000036 |
| FY 2022 | $110.8M | 2022-01-01 – 2022-12-31 | evidence 0001453687-23-000040 |
| FY 2021 | $85.1M | 2021-01-01 – 2021-12-31 | evidence 0001453687-22-000051 |
| FY 2020 | $16.6M | 2020-01-01 – 2020-12-31 | evidence 0001453687-21-000031 |
| FY 2019 | $6.7M | 2019-01-01 – 2019-12-31 | evidence 0001453687-20-000028 |
| FY 2018 | $903.0k | 2018-01-01 – 2018-12-31 | evidence 0001453687-19-000032 |
| FY 2017 | $207.0k | 2017-01-01 – 2017-12-31 | evidence 0001453687-19-000032 |
| FY 2016 | $8.1M | 2016-01-01 – 2016-12-31 | evidence 0001453687-19-000032 |
| FY 2015 | $6.0M | 2015-01-01 – 2015-12-31 | evidence 0001453687-17-000014 |
| FY 2014 | $3.0M | 2014-01-01 – 2014-12-31 | evidence 0001453687-17-000014 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
CARTESIAN THERAPEUTICS, INC. — all facts · Net Income · Operating Income